Invention Application
- Patent Title: C-TERMINAL FRAGMENT OF TETANUS TOXIN (HC) FOR TREATMENT OF DEPRESSION
-
Application No.: US17729502Application Date: 2022-04-26
-
Publication No.: US20220249602A1Publication Date: 2022-08-11
- Inventor: Yousef TIZABI
- Applicant: HOWARD UNIVERSITY
- Applicant Address: US DC Washington
- Assignee: HOWARD UNIVERSITY
- Current Assignee: HOWARD UNIVERSITY
- Current Assignee Address: US DC Washington
- Main IPC: A61K38/16
- IPC: A61K38/16

Abstract:
C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) provides therapeutic effects in motor impairments associated with Parkinson disease (PD), and provides long lasting antidepressant effects, thus useful in treating and mitigating depression, particularly PD-depression co-morbid condition. A method for treating or mitigating depression, including administrating an effective amount of C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) to a subject in need thereof. A method for treating or mitigating motor impairments associated with Parkinson's disease (PD), including administrating an effective amount of C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) to a subject in need thereof.
Public/Granted literature
- US12168035B2 C-terminal fragment of tetanus toxin (HC) for treatment of depression Public/Granted day:2024-12-17
Information query
IPC分类: